The structure of Pneumocystis carinii dihydrofolate reductase to 1.9 A resolution.
BACKGROUND: The fungal pathogen Pneumocystis carinii causes a pneumonia which is an opportunistic infection of AIDS patients. Current therapy includes the dihydrofolate reductase (DHFR) inhibitor trimethoprim which is selective but only a relatively weak inhibitor of the enzyme for P. carinii. Deter...
Κύριοι συγγραφείς: | Champness, J, Achari, A, Ballantine, S, Bryant, P, Delves, C, Stammers, D |
---|---|
Μορφή: | Journal article |
Γλώσσα: | English |
Έκδοση: |
1994
|
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
The structure of Pneumocystis carinii dihydrofolate reductase to 1.9 A resolution.
ανά: Champness, J, κ.ά.
Έκδοση: (1994) -
Preliminary crystallographic data for Pneumocystis carinii dihydrofolate reductase.
ανά: Stammers, D, κ.ά.
Έκδοση: (1993) -
Refolding of recombinant Pneumocystis carinii dihydrofolate reductase and characterization of the enzyme.
ανά: Delves, C, κ.ά.
Έκδοση: (1993) -
The binding of trimethoprim to bacterial dihydrofolate reductase.
ανά: Baker, D, κ.ά.
Έκδοση: (1981) -
Synthesis of 2,4-Diaminopteridines with Bulky Lipophilic Groups at the 6-Position as Inhibitors of Pneumocystis carinii, Toxoplasma gondii, and Mammalian Dihydrofolate Reductase
ανά: Rosowsky Andre, κ.ά.
Έκδοση: (1997-09-01)